In some people with non-Hodgkin lymphoma (NHL), treating a single tumor with an in situ vaccine can help to shrink, or eliminate, tumors in other parts of the body, findings from a small clinical trial suggest.
from Cancer Currents: An NCI Cancer Research Blog http://bit.ly/2J5L5Dn